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Introduction
Ad vances in the treat ment and pre ven tion of in fec tious dis eases, to gether with in creased stan dards of liv ing have led to a rapid increase in life ex pectancy over the last cen tury [1] . How ever, this has dri ven a sig nif i cant in crease in the num ber of older peo ple with multi mor bid ity and dis abil ity that im pair qual ity of life and pro duc tiv ity [2] . There fore, re search in ag ing bi ol ogy largely fo cusses on de lay ing https://web8.elsevierproofcentral.com/en/index.html?token=SPIPY2585ce47a2ef56ad6bec136af5c02e2d&type=AU
Advanced Drug Delivery Reviews xxx (2018) xxx-xxx gence of many ag ing mech a nisms with car diometa bolic dys func tion [10] . This im por tance of meta bolic path ways in ag ing bi ol ogy is ev idenced by the fact that the most ro bust in ter ven tion that de lays ag ing is the nu tri tional in ter ven tion called "caloric re stric tion" (CR). First de scribed in 1935 by Clive McKay et al. [11] , CR is usu ally de fined as a re duc tion in to tal calo rie in take by 20-40% with mi cronu tri ent sup ple men ta tion to pre vent spe cific mal nu tri tion dis or ders. Life long CR in creases mean and max i mal lifes pan by 30-50% in ro dents, dogs, flies, yeast, worms, mon keys and prokary otes [2] . There is also lim ited ev i dence in hu mans that CR in flu ences life ex pectancy and re duces the de vel op ment of dis eases [12] as well as the ag ing process it self [13] . Mice that are sub jected to CR are leaner, more in sulin sensi tive, glu cose tol er ant and have re duced in ci dence of dis ease [29] .
The ef fects of CR on ag ing are con served across a range of species, in di cat ing that there are fun da men tal cel lu lar path ways link ing nu trition with ag ing and health. Re search in this area has led to the iden tifi ca tion of sev eral key nu tri ent sens ing path ways that reg u late ag ing (in sulin/ IGF1/ GH sig nal ing, SIRT1, AMPK and mTOR) [2] , which in ver te brates are most strate gi cally lo cated in the liver, be cause it is the mas ter reg u la tor or gan of sys temic me tab o lism. The liver reg u lates most meta bolic path ways in clud ing glu cose me tab o lism via gly col y sis, glu cose up take and glu co neo ge n e sis [14] ; the for ma tion and pack ag ing of cho les terol and other lipids; and insulin sen si tiv ity (Table 1) [15, 16] . In gested sub stances that are absorbed from the gut travel to the liver via the por tal vein [17] , which Table 1 Ag ing and he patic me tab o lism, ef fects of caloric re stric tion and drug treat ments Summary of age-related changes in the liver and treatments with caloric restriction and drugs that delays the aging process Reference
Increased protein synthesis and burden of misfolded proteins producing oxidative stress and damage occur in the liver proteome of aging mice. This burden is reduced following 40% CR or rapamycin [189] Increased lipogenesis gene expression, cholesterol synthesis and lipid storage are observed in the aging mice liver. CR promotes the reprogramming of mice liver lipidome [190] [191] [192] Decreased hepatic autophagy has been demonstrated in multiple species with age, impairment leads to accumulation intracellular oxidative proteins, lipid droplets, lipofuscin and impaired mitochondrial function. Hepatic amino acid, glucose and free fatty acid metabolism are impaired. Acceleration of hepatic related diseases. Resveratrol (200 mg/kg) and 30% CR have been shown to promote SIRT1 mediated autophagy and improve oxidative protein stress. [83, 193, 194] Insulin signalling and sensitivity is reduced in aging rats and mediated via visceral fat content. Treatment with resveratrol, Metformin and CR promote increased insulin sensitivity in aged rats [65, [195] [196] [197] [198] Hepatic glycolysis, glycogenesis and glucose uptake are all decreased with aging. FOXO genetic manipulation demonstrates its role in hepatic gene regulation of gluconeogenesis, glycolysis and lipogenesis. SIRT1 and PGC-1α activation promote increased gluconeogenesis and reduced glycolysis in the liver [65, 96, 196, 199, 200] SIRT1 and mitochondrial biogenesis are reduced in aging mice; SIRT1-mediated HIF-1α and PGC-1α activity regulate mitochondrial biogenesis. CR and resveratrol treatments promote improved mitochondrial function in aging mice [44, 98, 178] Aging mice livers demonstrate increased inflammation, cellular stress, and fibrosis, with decreased apoptosis, xenobiotic metabolism, cell-cycling and DNA replication genomic profiles. 40% CR for a month was shown to improve these profiles in mice. [96] also con tains pan cre atic hor mones in clud ing in sulin, glucagon and Cpep tide [18, 19] . The he patic mi crovas cu la ture is highly spe cial ized to op ti mize the bidi rec tional ex change of sub strates be tween blood and he pa to cytes. The en dothe lial cells that line this si nu soidal mi crovascu la ture (the "he patic si nu soids") are called liver si nu soidal en dothelial cells (LSEC) and are per fo rated with pores called "fen es tra tions" that fa cil i tate size-se lec tive siev ing of blood-borne mol e cules for uptake by he pa to cytes [20, 21] . The term "pseudo cap il lar iza tion" refers to age-re lated changes in the LSEC in clud ing a re duc tion in the size and num ber of fen es tra tions, which leads to im paired up take of some sub strates. Old age is as so ci ated with re duc tion in liver me tab o lism due to three main fac tors: re duced meta bolic ca pac ity due to di minished liver size and/ or en zyme ac tiv ity; de creased liver blood flow; and re duced trans fer of metabo lites and mol e cules from the si nu soids to the he pa to cytes [22, 23] . To gether, these changes im pact many facets of he patic me tab o lism of sub strates such as lipopro teins, drugs and in sulin [24] [25] [26] thus po ten tially con tribut ing to in sulin re sis tance, vas cu lar dis ease and ad verse drug re ac tions [7, 27, 28] .
Here we dis cuss these two he patic drug tar getsnu tri ent sens ing path way in he pa to cytes; and fen es tra tions in LSECsthat might impact on sys temic and he patic ag ing. We also dis cuss the pos si bil ity of us ing nanomed i cines to pre cisely de liver fen es tra tion-ac tive agents di rectly to the LSECs.
Targeting the nutrient sensing pathways
Nu tri ent sens ing path ways reg u late adap tive cel lu lar re sponses to chang ing nu tri ent avail abil ity such as famine or food ex cess. Dur ing times of nu tri ent scarcity, these path ways pro mote the sur vival and re silience of an or gan ism at the cost of re duced re pro duc tive ca pac ity. Pre sum ably these path ways have evolved to pro mote re pro duc tion only when there are suf fi cient nu tri ents to en sure the sur vival of offspring. In mul ti cel lu lar or gan isms nu tri ent sens ing path ways form com plex net works that de tect, or ga nize, use, re con sti tute and me tab olize nu tri ents [29] . The down stream phys i o log i cal con se quences of ac ti vat ing or an tag o niz ing these path ways (for ex am ple by CR, or drugs that are thought to mimic CR) are shown in Table 1 [40] . Manip u la tion of these path ways through CR or ge netic in ter ven tions has been shown to al ter the bi o log i cal process of ag ing, me dian and maxi mal lifes pans and the in ci dence of many age-re lated dis eases. The four canon i cal nu tri ent sens ing path ways in ter act with each other and share many down stream tar gets that reg u late cel lu lar processes that are crit i cal for ag ing in clud ing mi to chon dr ial bio gen e sis, cel lu lar metab o lism, au tophagy, DNA re pair and ex pres sion, and trans la tion (Fig ure 1) .
With in creas ing age, there are changes in the ex pres sion and ac tivity of the four nu tri ent sens ing path ways: in sulin/ IGF-1, mTOR, AMPK, and the Sir tuin/ NAD path ways [16, 30, 31] . Within the key or gans in volved in home o sta tic meta bolic reg u la tionliver, pancreas, mus cle and fatthese changes are as so ci ated with other ag ing processes such as ox ida tive stress [32] and in flam ma tion [29, 33, 34] . To gether these processes in these or gans con tribute to im paired systemic me tab o lism, which in turn is linked mech a nis ti cally with di abetes, car dio vas cu lar dis ease, can cers and neu rode gen er a tion [5, 31, 33, 35] . Al though the ma jor in ter ven tions used are CR and genetic over ex pres sion or knock out mod els [36, 37] , re cently phar ma colog i cal ma nip u la tion of these path ways with agents such as metformin, ra pamycin and resver a trol, has been shown to de lay the ag ing process, at least in lab o ra tory an i mal mod els [38] [39] [40] .
Ther a peu tic agents re ca pit u late the ef fects of CR on ag ing have been termed "CR-mimet ics" [41] which pri mar ily tar get in di vid ual com po nents of the nu tri ent sens ing path ways. Al though these drugs have been used to treat in di vid ual dis eases in the past, it is pos si ble that their ben e fi cial ef fect is in part sec ondary to de lay the ef fect of ag ing on these dis eases. More over, in some stud ies in an i mal mod els, CR mimet ics have been found to in crease me dian and max i mal lifespan, prob a bly by de lay ing the on set of ag ing [16, 42, 43] .
The main fea tures of these nu tri ent sens ing path ways are as follows:
Mechanistic target of rapamycin (mTOR)
mTOR is a ser ine/ thre o nine pro tein ki nase that reg u lates cell growth, pro lif er a tion, motil ity, pro tein syn the sis and au tophagy. mTOR in te grates in put from var i ous path ways, in clud ing in sulin and IGF-1, and re sponds to di etary pro tein, par tic u larly the branchedchain amino acids. mTOR ex ists in two dif fer ent com plexes mTORC1 and mTORC2, which are dif fer en ti ated by their ac ces sory pro teins, Rap tor and Ric tor, and only mTORC1 is sen si tive to amino acids [44] . Ra pamycin is a po tent in hibitor of mTOR that was initially uti lized as an im muno sup pres sive drug for pa tients fol low ing re nal trans plants. It has now been as so ci ated with in creased lifes pan in mice fed stan dard di ets [45, 46] and hu man stud ies into the ef fects of ra pamycin on healthy el derly pa tients are cur rently be ing performed [30, 47] .
5' Adenosine monophosphate-activated protein kinase (AMPK)
AMPK reg u lates cel lu lar up take of glu cose, β-ox i da tion of fatty acids, the glu cose trans porter 4 (GLUT4), and mi to chon dr ial bio gene sis. AMPK is ac ti vated in re sponse to in creased cel lu lar AMP:ATP ra tio. CR is as so ci ated with in creased AMPK ac tiv ity as a con sequence of re duced en ergy in take. Met formin en hances lifes pan in mice and this is ac com pa nied by an in crease in AMPK ac tiv ity [39] . In hu mans, met formin has been shown to re duce the pro gres sion of di a betic im pair ment of glu cose tol er ance by 31%, re duce ath er o sclero sis de vel op ment [48] [49] [50] and a sys tem atic re view has demon strated im proved car dio vas cu lar mor tal ity by 25% [51, 52] . Ad di tion ally a recent sys tem atic re view found that met formin pro motes a sig nif i cantly lower mor tal ity in di a betic pa tients com pared to non-di a bet ics and also di a bet ics that were not on met formin [53] . Hu man ob ser va tional stud ies have con cluded that met formin de creases the risk of the most com mon dis eases of ag ing: car dio vas cu lar dis ease [54] [55] [56] , can cer [57] , de pres sion [58] , frailty [54] , mild cog ni tive im pair ment [59] and de men tia [60, 61] . Clin i cal tri als in hu mans to eval u ate its ef fects on dis ease sus cep ti bil ity and ag ing bi ol ogy (in cluded tran scrip tome) are planned.
Sirtuin pathway (SIRT1)
Sir tu ins are class III hi s tone deacety lases that re quire NAD as a co fac tor. CR in creases cel lu lar NAD as a con se quence of re duced en ergy in take, thereby ac ti vat ing sir tu ins. While the sir tuin fam ily con sists of seven mem bers [62] , in mam mals, the key ag ing ho molog is SIRT1 which deacety lates key hi s tone residues in volved in the regu la tion of tran scrip tion and mul ti ple non-hi s tone pro tein tar gets rel evant to ag ing (p53, FOXO, PGC-1α, NF-κB) [37, 63] . A num ber of phar ma co log i cal agents that al loster i cally ac ti vate SIRT1 de lay ag ing (Sir tuin Ac ti vat ing Com pounds, known as STACs) in clud ing resver atrol and SRT2014 [40, [64] [65] [66] [67] . STACs pro mote al losteric ac ti va tion of SIRT1 and dif fer in their po tency and op ti miza tion in the ac ti va tion of sir tuin [68] . STACs mimic CR, in crease mi to chon dr ial func tion and pro tect against meta bolic and car dio vas cu lar dis ease pro gres sion by re duc ing meta bolic risk fac tors [66, 68] . No tably resver a trol increased lifes pan in mice fed a high fat diet [65] but not in mice on stan dard chow where only health ben e fits were ob served [46, 69] . This sug gests that ac ti va tion of the SIRT1 path way may have its great est ef fect on ag ing where there is high en ergy in take and great est in hi bi tion of SIRT ac tiv ity. In ad di tion, ac ti va tion of SIRT1 with resver a trol treat ment in vitro pro moted en dothe lial pro tec tion via KLF-2 and MAPK5 [70] .
A com pre hen sive re view of hu man clin i cal tri als, has demonstrated in con sis tent find ings in older peo ple, with some show ing health ben e fits, par tic u larly in older hu mans with mul ti mor bidi ties such as type II di a betes, non-al co holic fatty liver dis ease (NAFLD) and coro nary artery dis ease [71] [72] [73] [74] [75] [76] [77] [78] . The dose, du ra tion and the source of resver a trol has var ied across many of the tri als and might ac count for some of the in con sis ten cies seen in ag ing hu man stud ies. More re cently nicoti namide mononu cleotide (NMN), and nicotinamide ri bo side (NR), biosyn thetic NAD metabo lites have been inves ti gated for their abil ity to aug ment NAD blood lev els [79] .
Insulin/ IGF-1signaling pathway (ISS)
The in sulin/ IGF-1 sig nal ing path way is con tin u ously mod u lated by di etary nu tri ent sta tus: plasma con cen tra tions of pro tein (IGF-1) and sug ars (in sulin) and ad di tion ally by the lev els of cir cu lat ing growth hor mone (GH) [30] . In sulin re lease is stim u lated by glu cose and branched-chain amino acids. GH stim u lates he patic pro duc tion of IGF-1 and acts on the IIS path way to mod u late in sulin sen si tiv ity [80] . Lower lev els of in sulin, IGF-1 and GH in duced by ei ther genetic vari abil ity or low en ergy di ets are as so ci ated with in creased lifes pan across taxa and in clud ing hu mans [36] .
Recent additions to the classic pathways
Au tophagy is an es sen tial cel lu lar process that pro motes cell survival, es pe cially as a cel lu lar star va tion re sponse, and reg u lates home osta sis. Au tophagy is up reg u lated in the set ting of low ATP and in sulin, re duced growth fac tor stim u la tion and JNK1-Be clin-1 de pendent cel lu lar stress [81] [82] [83] [84] . It fa cil i tates the degra da tion of un nec essary and dys func tional cel lu lar prod ucts, lib er at ing cel lu lar stores of en ergy [29, 85] . It has pre vi ously been high lighted in a re view by Gra cia-San cho, et al. [81] that au tophagy has an im por tant role in inhibit ing the de vel op ment of liver dis eases such as NAFLD, how ever hall marks of NAFLD: hy per glycemia and im paired he pa to cel lu lar clear ance of lipids im pairs au tophagy, sug gest ing that tar get ing autophagy path ways may be ben e fi cial in the treat ment of NAFLD and other fatty liver dis or ders.
An other re cent po ten tial ad di tion to these four clas si cal nu tri entsens ing path ways is Fi brob last Growth Fac tor 21 (FGF21). FGF21 is pro duced by the liver and is in creased in re sponse to acute star va tion, with a re cent study show ing that low pro tein in take is the ma jor stimu lant for its ex pres sion and blood lev els [86, 87] . It reg u lates sev eral meta bolic func tions (glu co neo ge n e sis, mi to chon dr ial ac tiv ity, ke to gen e sis, lipid me tab o lism) which im pact on age-re lated health. FGF21 in ter acts with the other nu tri ent-sens ing path ways by ac ti vat ing AMPK and SIRT1 [88] , sug gest ing a key role for FGF21 in link ing nu tri tion and ag ing. Para dox i cally in hu mans, higher lev els of FGF21 are as so ci ated with obe sity and di a betes, prob a bly re flect ing FGF21 re sis tance in these con di tions. The role of FGF21 in ag ing and nu trition is now a key fo cus for ag ing re search [89] . 
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Targeting the liver in aging
As de scribed above, the liver is a key reg u la tor of me tab o lism, with sig nif i cant age-re lated changes in func tion sec ondary to re duced liver size and en zyme ac tiv ity, blood flow and transendothe lial transfer [20, 22, 23, [90] [91] [92] [93] . This im pairs detox i fi ca tion and clear ance of var i ous en do bi otics (e.g. lipopro teins and in sulin) [94] and xeno biotics (e.g. drugs, neu ro tox ins and car cino gens) [95] . Many processes con tribute to re duced meta bolic en zyme ac tiv ity and cel lu lar dam age in the ag ing liver, in clud ing the ef fects of ag ing on ox ida tive stress, in flam ma tion, stress re sponses [96] , au tophagy and apop to sis [96, 97] , and mi to chon dr ial func tion [98] . The re duc tion in blood flow to the liver re flects a gen eral down reg u la tion of splanch nic blood flow in all ab dom i nal or gans rather than any spe cific he patic ef fects on vascu lar re sis tance. The re duc tion in the trans fer of sub strates be tween blood and he pa to cytes oc curs mainly as a re sult of the loss of fen estra tions as so ci ated with pseudo cap il lar iza tion [2, 24, 25, 94, 95, 99] . All these ag ing liver changes will im pact on the re spon sive ness and activ ity of the nu tri ent sens ing path ways.
Age-re lated changes in liver cells also con tribute to the in creas ing risk of the de vel op ment of liver dis eases with older age. The ac cu mula tion of ox ida tive stress and age-re lated changes in in flam ma tion favors the pro gres sion to wards NAFLD, steato hep ati tis and he pa to cellu lar car ci noma [100] . The de vel op ment of NAFLD in volves im pairment of LSEC func tions through im paired reg u la tion of ni tric ox ide syn thase and loss of fen es tra tions, with these fea tures de vel op ing prior to the rise seen in in flam ma tory mark ers [101] [102] [103] . This suggests that tar get ing LSECs may, in ad di tion to pro mot ing healthy aging, be rel e vant to pre vent ing the de vel op ment of NAFLD and its pro gres sion to steato hep ati tis (Fig. 1 ).
Liver sinusoidal endothelial cells
LSECs have a highly spe cialised mor phol ogy. They are per fo rated by nu mer ous nano-holes/ pores [104] [105] [106] , called fen es tra tions, with di am e ters in the range 50-200 nm. More over, there is no un der ly ing base ment mem brane in the ex tra cel lu lar space of Disse. LSECs possess highly ef fi cient en do cytic ca pac ity, tran scel lu lar trans porta tion and im mune-me di ated path ways [107] [108] [109] [110] [111] that also con tribute to the trans fer of sub strates be tween the blood and space of Disse. LSECs re tain blood cells within the si nu soidal lu men while al low ing the bidi rec tional pas sage through the fen es tra tions of sub stances such as dis solved or al bu min-bound drugs, pro teins, lipopro teins, and small viruses (Fig. 2) . Lit tle is known about the dy namic struc ture and regu la tion of fen es tra tions. To date the ma jor ity of stud ies on LSEC fenes tra tions have uti lized elec tron mi croscopy and fixed cells or tis sue, but new su per-res o lu tion op ti cal meth ods are now avail able [112] [113] [114] [115] [116] , which can vi su al ize fen es tra tions in un fixed and/ or live LSEC, and their re sponses to stim uli over time [112, 115] . This will fa cil i tate the dis cov ery and test ing of drugs that can in flu ence fen estra tions.
LSEC are po tent scav engers, be long ing to the fam ily of "scavenger en dothe lial cells" [110] , which also in cludes bone mar row sinu soidal en dothe lial cells [117, 118] and chori o cap il laris en dothe lial cells [119] . LSECs clear sol u ble waste in clud ing hyaluro nan [120] [121] [122] [123] , ad vanced gly ca tion end-prod ucts [109, 124, 125] , im mune com plexes [126] , col la gen al pha-chains [127, 128] , oxLDL [129] or nano-par ti cles (<200 nm) such as viruses [111] and quan tum dots [130] via clathrin me di ated en do cy to sis, while the liver res i dent macrophages (Küpf fer cells) clear par tic u late mat ter larger than 200 nm [110] . This di vi sion of labour is called the "dual-cell prin ci ple of waste clear ance", a con cept first in tro duced by Sørensen et al. [110] . With the si nu soidal sur face area equal to the size of a ten nis court, the liver si nu soid is the most po tent scav eng ing sys tem in the body. Con se quently, the LSEC has be come the bane of nano-par ti cle and an ti sense oligonu cleotide based ther a pies that aim to tar get other tis sues [131] , but it can be an ad van tage if the liver si nu soid it self is the tar get.
Aging LSECs
LSECs un dergo mor pho log i cal and func tional trans for ma tions in dis ease and ag ing. One key change is the loss of fen es tra tions, termed "de fen es tra tion", of ten as so ci ated with the de po si tion of a base ment mem brane [132] . "Cap il lar iza tion" is the term used to de scribe the com bi na tion of de fen es tra tion, base ment mem brane syn the sis and altered ex pres sion of en dothe lial pro teins which are seen in var i ous chronic liver dis eases in clud ing cir rho sis [133] , pri mary bil iary cirrho sis [134] , chronic he pati tis [108] , and vi ral in fec tions [135] . "Pseudo cap il lar iza tion" is the term used to de scribe sim i lar, but distinct age-re lated changes which oc cur in the LSEC with out the sig nif i cant stel late cell ac ti va tion or bridg ing fi bro sis seen with chronic liver dis ease [20, 24, 25, 91, [136] [137] [138] [139] [140] . Ag ing is also as so ci ated with mor pho log i cal and/ or func tional changes with the other cells of the he patic si nu soid, namely stel late cells and Küpf fer cells [21] . LSECs in old age had markedly re duced poros ity (% of LSEC sur face area per fo rated by fen es tra tions) as so ci ated with in creased cross-sec tional thick ness of the LSEC in a va ri ety of species from mice to hu mans. These age-re lated mor pho log i cal changes are ac com pa nied by al tered ex pres sion of many vas cu lar pro teins in clud ing von Wille brand's factor, ICAM-1, laminin, cave olin-1 and var i ous col la gens on LSEC and in the space of Disse [141] but with out other fea tures of liver dis eases [142] . Thre is re duced scav eng ing ca pac ity in old mice [143] at the level of en do cy to sis, as old LSECs were able to de grade en do cy tosed lig and equally well as young LSECs once it was en do cy tosed. However, there was no ap par ent age-re lated change in the amount of the re cep tors re spon si ble for en do cy to sis (sta bilin-1 and -2 scav enger recep tors), so it was con cluded that thick en ing of LSEC was re tard ing the trans port of in ter nal ized lig and to the endo/ lyso so mal com partment thus slow ing the en do cytic processthe "traf fic jam" hy poth esis [143] . De spite the loss of ap prox i mately one third of their en docytic ca pac ity, LSEC re main po tent scav engers in ag ing liv ers.
Implications of age-related defenestration
Age-re lated loss of fen es tra tions has a sig nif i cant im pact on the trans fer of sub stances across the en dothe lium (Fig. 2) . Fen es tra tions al low pas sage of smaller lipopro teins in clud ing chy lomi cron remnants, while ex clud ing larger par ti cles such as chy lomi crons and platelets. Old age is as so ci ated with im paired he patic clear ance of chy lomi cron rem nants and the clin i cal man i fes ta tion of post pran dial hy per triglyc eridemia. The lat ter is more closely as so ci ated with adverse car dio vas cu lar out comes in older peo ple than clas si cal dys lip idaemias [136] . Us ing the mul ti ple in di ca tor di lu tion method in perfused rat liv ers, [24] it was shown that the trans fer of lipopro teins (av er age di am e ter 53 nm) across the LSEC was al most to tally abolished in liv ers from old rats. This pro vides a novel mech a nism for age-re lated dys lipi demia and post pran dial hy per lip i daemia [24] and may be a sig nif i cant con trib u tor to age-re lated hy per lip i daemia [144] and, hence, vas cu lar dis ease.
Old age is also as so ci ated with in sulin re sis tance and a marked increase in di a betes mel li tus. Us ing mul ti ple in di ca tor di lu tion meth ods in per fused liv ers, [25] it was demon strated that in sulin trans fer across LSEC is im paired in old age. Older rats showed a sig nif i cant re duc tion in the he patic vol ume of in sulin dis tri b u tion, con sis tent with the re stric tion of in sulin to the vas cu lar space. This was confirmed by whole an i mal in sulin and glu cose up take stud ies which showed re duced he patic in sulin up take and con comi tant re duced ac tiva tion of the in sulin re cep tor sub strate 1 and in sulin path ways in old rats. Mea sure ments of glu cose tol er ance, HOMA-IR, blood lev els of in sulin, C-pep tide and glucagon showed that the re duced in sulin action in the liver was as so ci ated with sys temic im pair ment of in sulin and glu cose me tab o lism [25] . These find ings re veal that fen es tra tions in flu ence he patic in sulin up take. Con versely, PDGF-B de fi cient mice have in creased fen es tra tions which was as so ci ated with in creased trans-en dothe lial trans port, dra mat i cally lower cir cu lat ing in sulin levels, in creased in sulin clear ance and im proved in sulin sen si tiv ity [145] .
Ag ing is as so ci ated with im paired he patic me tab o lism and elim ina tion of many drugs, usu ally in creas ing the risk of dose-de pen dent ad verse drug re ac tions [26] . The re duc tion in he patic drug me tab olism with ag ing [146] can in part be ex plained by changes in the trans-en dothe lial trans port of drugs across the liver si nu soid [147] . For ex am ple, he patic sin gle pass clear ance of ac eta minophen is reduced in ag ing rats sec ondary partly to pseudo cap il lar iza tion of the LSEC [148, 149] . This may ex plain the age-re lated de crease in suscep ti bil ity to parac eta mol-in duced he pa tox i c ity but the in crease in nephro tox i c ity.
There fore strate gies that main tain fen es tra tion poros ity dur ing aging, or in crease fen es tra tions in older peo ple have the po ten tial to improve dys lipi demia and he patic in sulin re sis tance, thereby pro vid ing a novel ap proach for the treat ment and pre ven tion of car diometa bolic risk fac tors in older peo ple [150] .
Novel targets to reduce liver aging
In or der to dis cover drug tar gets that main tain fen es tra tions into old age, it is nec es sary to un der stand the prox i mate bi o log i cal processes that reg u late fen es tra tions. The most po tent agents for in 03/10/2018, 08)17 Page 6 of 13 https://web8.elsevierproofcentral.com/en/index.html?token=SPIPY2585ce47a2ef56ad6bec136af5c02e2d&type=AU
Advanced Drug Delivery Reviews xxx (2018) xxx-xxx creas ing fen es tra tions are vas cu lar en dotheial growth fac tor (VEGF) and var i ous actin cy toskele ton dis rup tors [151] . These are mech a nisti cally linked be cause VEGF acts via its ef fects on the actin cytoskele ton [152] . A ma jor con cep tual ad vance oc curred when 3Dstruc tured il lu mi na tion su per res o lu tion mi croscopy was used to vi sual ize LSECs [112] , re veal ing the mor pho log i cal re la tion ship be tween fen es tra tions and lipid rafts. It was shown that sieve plates (which are clus ters of con tain ing 10-100 fen es tra tions) were in ter ca lated between thick ened ar eas of mem brane iden ti fied as lipid rafts [112] . Dis rup tion of lipid rafts and/ or actin cy toskele ton in creased fen es trations while de ple tion of non-raft mem brane de creased fen es tra tions. Agents that de pleted non-raft mem brane pre vented actin dis rup tors from in creas ing fen es tra tions, thereby prov ing that actin dis rup tion in creases fen es tra tions di rectly by its ef fects on mem brane rafts. VEGF both de pleted lipid rafts and in creased fen es tra tions [115] [153] . The re sults are con sis tent with a 'sieve-raft' in ter ac tion model, where fen es tra tions form in non-raft re gions of en dothe lial cells once the mem brane-sta bi liz ing ef fects of actin cy toskele ton and mem brane rafts are di min ished [154] . The sieve-raft model pro vides a uni fy ing mech a nis tic path way for the ef fects of drugs and other agents that have been re ported to in crease or de crease fen es tra tions (Fig. 3) . Pre ven tion of age-re lated de fen es tra tion has been achieved ei ther by us ing agents that act on nu tri ent sens ing path ways and de lay ag ing more gen er ally; and those that act on spe cific path ways that ap pear to reg u late fen es tra tions di rectly. So far two drugs that de lay ag ing process have been ex am ined and shown to pre vent age-re lated de fenes tra tion: resver a trol and met formin.
Resver a trol, which acts on the sir tuin nu tri ent sens ing path way, has been shown to in crease fen es tra tions in a Werner Syn drome mouse, which is a model for pre-ma ture ag ing [155] . Met formin, which acts on the AMPK nu tri ent sens ing path way, in creased fen estra tion poros ity in old mice and im proved HOMA-IR and in sulin sensi tiv ity [156] .
A num ber of agents that act di rectly on the path ways as so ci ated with the reg u la tion of fen es tra tions as de scribed above have been tested for their ef fects on age-re lated de fen es tra tion. The sero tonin recep tor ag o nist, 2,5-dimethoxy-4-iodoam phet a mine (DOI) pro moted in creased poros ity in young LSECs in vitro [157] , as well as in old mice in vivo [158] . The ef fects of DOI were shown to be mod u lated by both VEGF de pen dent and in de pen dent mech a nisms. Re cent data [159] have demon strated the util ity of mul ti ple phar ma ceu ti cal agents in pro mot ing in creased fen es tra tion di am e ter and fre quency in isolated LSECs from both young and old mice. These agents all act via the path ways pre vi ously dis cussed in this re view: ni tric ox ide de pendent path ways (silde nafil and am lodip ine); NAD pro mo tion (nicotinamide mononu cleotide); and cell sur face death re cep tor ac ti va tion (TRAIL) [159] .
Lastly, the use of statins has also been shown to pro mote im provement of au tophagy in the set ting of liver dis eases [53, [160] [161] [162] . While these drugs have not been specif i cally tested for this pur pose in ag ing pre vi ous find ings sug gest statin treat ment may im prove LSEC func tion through the pro mo tion of KLF-2 sim i larly to SIRT1 [70] and war rant fur ther in ves ti ga tion.
Nanoparticles target the LSEC
A fun da men tal chal lenge in de vel op ing phar ma cother a pies is target ing the ac tive agent to the de sired cell type or tis sue. For tu nately, LSECs have unique prop er ties that can be ex ploited as a dru gable target. The LSEC is the most ac tive and ef fi cient en do cytic cell in the body [163] and is densely pop u lated with clathrin coated vesi cles and nu mer ous en do cytic re cep tors (e.g. man nose re cep tors, sta bilin re ceptors, Fc gamma-re cep tor IIb2 [122, 127, 164, 165] ). This en do cytic machin ery is highly ef fi cient in up take and degra da tion of en doge nous and ex oge nous waste ma te r ial, in clud ing all ma jor classes of bi o log ical macro mol e cules. There fore, it is not sur pris ing that the LSEC has also proven to be tar get for the up take of nanopar ti cles, par tic u larly those with a di am e ter be tween 5-20 nm. [130, 166, 167] . There fore nanopar ti cles have been pro posed as an ef fi cient way of de liv er ing drugs to the LSEC and other liver cells [168, 169] (Fig. 3 ), re duc ing dosages, off-tar get ef fects and ad verse drug re ac tions. Such drug deliv ery tech nol ogy would be ideal for ther a peu tic agents that reg u late fen es tra tions in the LSEC.
Methods for targeted delivery to LSECs
Sev eral lig ands and/ or nanopar ti cles have been in ves ti gated for their abil ity to se lec tively tar get the LSEC with a va ri ety of drugs and ther a peu tic aims.
Specific ligands
Hyaluronic acid (HA) is in ter est ing be cause the ex pres sion of its en do cytic re cep tor, sta bilin-2, is re stricted to LSECs [170] , and the vast ma jor ity of HA is cleared by the liver. HA is found within the ex tra cel lu lar ma trix and syn ovial flu ids of most hu man tis sues, and HA is known to be bio com pat i ble, degrad able and non-toxic [171] . A re cent study uti lized HA-bound nanopar ti cles in com bi na tion with gly cyrrhetinic acid (binds to gly cyrrhetinic acid re cep tors ex pressed on he pa to cytes) to pro mote tar get ing within the liver [172] . HA-drug con ju ga tion has been suc cess fully de vel oped for the de liv ery of an ticancer drugs to the liver [173, 174] . also It has been pointed out that an ex ten sive range of sub strates (e.g. nanopar ti cles, nanogels, quantum dots, hy dro gels and or ganic mol e cules) have been bound to HA to tar get dif fer ent can cer types. Sev eral car ri ers with a high affin ity for sta bilin re cep tor 2 and man nose re cep tors (HA, oleyamine and poly sac cha ride chon droitin sul fate) on LSECs were found to fa cil i tate tar geted de liver of miRNA to re duce murine colon can cer metas ta sis [175] . Chem i cally mod i fied cy tokines with nat ural lig ands can tar get var i ous liver cell types. IL-10 con ju gated with thio phos gene-ac tivated man nose-6-phos phate in creased liver up take com pared to in travenous in jec tions of IL-10 alone which ac cu mu lated in the kid neys [176] . Re cep tors for man nose/ N-acetyl glu cosamine re cep tors are expressed on he pa to cytes, he patic satel lite cells, Küpf fer cells and LSECs [169] .
Formalde hyde-treated serum al bu min (FSA) may have po ten tial for drug de liv ery to the LSEC be cause it is avidly taken up by LSECs in vitro and in vivo [177] . In vivo, FSA was al most en tirely en do cytosed via sta bilin-2 re cep tors in the LSEC with only 2% of the dose taken up by other tis sues. [178] . FSA is rapidly en do cy tosed by LSECs within 5-10 mins of in tra venous in jec tion and is de graded with out he patic or LSEC tox i c ity [110, 179] .
Nanoparticles and quantum dots
Nanopar ti cles range in size from 1-500 nm (by de f i n i tion, one dimen sion must be within 1-100 nm). Nanopar ti cles demon strate (i) high motil ity in a free state, (ii) high sur face area, and (iii) may exhibit quan tum ef fects. Quan tum dots (QDs) are a type of nanopar ti cle that ex hibits quan tum ef fects and have a re stricted size (1-20 nm). QDs are semi con duc tor par ti cles that have dif fer ent op ti cal and conduc tive prop er ties than larger sized par ti cles. Nanopar ti cle and QD up take within the liver is di rected by sev eral prop er ties: size, com posi tion and ad di tional con ju gated fac tors. It has been shown us ing Cd/ Me QDs, that nanopar ti cles with a di am e ter of 3-4 nm are en do cytosed en tirely by LSECs [130] . By com par i son, poly eth yl ene gly col (PEG)-bound nanopar ti cles with a di am e ter of 50 nm are taken up by he pa to cytes [169] . PEG pro motes greater hy drophilic bind ing and reduces plasma pro tein bind ing within the cir cu la tion, which re duces phago cy to sis by Küpf fer cells. In stead PEG binds to man nose/ Nacetyl glu cosamine re cep tors ex pressed on he pa to cytes, LSECs and Küpf fer cells lead ing to en do cy to sis pri mar ily by he pa to cytes [169] . γ-Fe O QDs en cap su lated within a mod i fied PEG poly mer were found to un dergo fa cil i tated en do cy to sis into a ED25 cell line; futhurmore the use of a poly meric mi celles was shown to ame lio rate tox i city in duced by Fe O QDs .
Ba sic nanopar ti cles with a di am e ter of >250 nm are taken up prefer en tially by Küpf fer cells [180, 181] . This is be cause nanopar ti cles of this di am e ter are too large to pass through fen es tra tions for he pa tocyte up take; in stead they re main in the si nu soidal lu men. Küpf fer cells gen er ally phago cy tose par ti cles rang ing in size from 150-300 nm in di am e ter [182] . How ever, Küpf fer cells and LSECs took up 50% of nanocrys tals mod i fied with DSPE-PEG that had a di am e ter of just 4-8 nm [183] . It ap pears that both the size and com po si tion of nanopar ti cles de ter mine which cell type is pref er en tially tar geted [174] .
Mer cap to suc cinic acid-capped cad mium tel luride/ cad mium sulfide (CdTe/ CdS) quan tum dots (QDs) have pre vi ously been shown to ac cu mu late se lec tively in the LSEC with min i mal en do cy to sis by Küpf fer cells fol low ing in tra venous in jec tions in vivo in rats [130] . CdTe/ CdS QDs are neg a tively charged nanopar ti cles that are en do cytosed by scav enger re cep tors on LSECs and Küpf fer cells [130] . The lim i ta tion of these QDs was the failed clear ance via the bile three hours post treat ment: this was sug gested to con tribute to their tox i c ity in LSECs.
Iron ox ide nanocrys tals or Cd-Se lenide/ CdS/ Zinc-S (core, shell, shell) QDs en cap su lated in a am phiphilic poly mer (poly(maleic an hy dride-alt-1-oct dencene)) have been used to pro mote se lec tive up take into the liver, par tic u larly LSECs [184] . These nanopar ti cles were non-toxic four weeks post-in jec tion with no changes in cell death detected with a TUNEL as say [184] . How ever, pre vi ous stud ies with iron ox ide nanocrys tals high lighted cel lu lar changes in actin and tubu lin, and low doses of iron may pro mote cel lu lar stress path ways based on stud ies per formed in HU VECs [185] .
Lipophilic, hy dropho bic HA-based nanocap sules tar get LSECs with ap par ently less tox i c ity than other nanopar ti cles [186] . These nanocap sules se lec tively tar get LSECs and pul monary mi crovas cu lar en dothe lial cells. The nanocap sules con sist of a liq uid oil (oleic acid) core sta bi lized by hy dropho bic mod i fied HA. The struc ture is between 100-150 nm in di am e ter and sta ble for 15 months in vivo. Both in tra venous and oral forms of ad min is tra tion were ob served to promote ac cu mu la tion within the liver within 1 h for in tra venous and within 6 ho for oral de liv ery. Clear ance was con firmed in urine of the sta ble nanocap sule 6 h post ad min is tra tion with min i mal ex pres sion in plasma. These char ac ter is tics were con sid ered by the au thors to be favor able for drug de liv ery to the liver.
An other in ter est ing nanopar ti cle for the de liv ery of agents to the LSEC is MEND (mul ti func tional en ve lope-like nanocap sule de vice). This nanopar ti cle is com posed of cho les terol and PEG-DMG (1, 2dimyris toyl-sn-glyc ero, methoxy eth yl ene gly col 2000 ether) combined with a cationic lipid (YSK05) to fa cil i tate the en do so mal escape of MEND. MEND is tar geted to LSECs and he pa to cytes via steary lated KLGR, a novel LDL re cep tor mol e cule [187] and its 84-118 nm di am e ter. This nanopar ti cle has been used to de liver siRNA to down reg u late Tie2 ex pres sion in he pa to cytes and LSECs [188] and has been shown to acts via mi cropinocy to sis rather than clathrin-medi ated en do cy to sis.
Summary
Path ways that reg u late the meta bolic re sponses to nu tri tion by the liver are a plau si ble tar get for de lay ing ag ing. Di ets and drugs that influ ence the canon i cal nu tri ent sens ing path ways in the liver are be ing ex ten sively stud ied. How ever, there are also age-re lated changes in the liver mi cro cir cu la tion that in flu ence the reg u la tion of me tab o lism by the liver, par tic u larly the me tab o lism of lipopro teins and in sulin sen si tiv ity. There are sev eral drugs and other agents that can in crease fen es tra tions in LSECs from old an i mals. Such agents, cou pled to nanopar ti cles that are se lec tively taken up by LSECs, may prove to be a novel ther a peu tic tar get for the pre ven tion and treat ment of agere lated dys lipi demia and in sulin re sis tance. https://web8.elsevierproofcentral.com/en/index.html?token=SPIPY2585ce47a2ef56ad6bec136af5c02e2d&type=AU U scrip tional land scape of age in hu man pe riph eral blood, Na ture Com mun (2015) 6. 
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